RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
Objective The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID− 19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID− 19 severity. We set-up a multicenter …
[HTML][HTML] RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 …
THE COVID - Vascular Pharmacology, 2020 - ncbi.nlm.nih.gov
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an
observational multicenter study in Italy and a meta-analysis of 19 studies - PMC Back to Top …
observational multicenter study in Italy and a meta-analysis of 19 studies - PMC Back to Top …
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
A Di Castelnuovo, S Costanzo, A Antinori… - VASCULAR …, 2020 - air.unimi.it
Objective: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
A Di Castelnuovo, S Costanzo, A Antinori… - VASCULAR …, 2020 - iris.unipv.it
Objective: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID− 19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID− 19 severity. We set-up a multicenter …
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
A Di Castelnuovo, S Costanzo, A Antinori… - VASCULAR …, 2020 - research.unipd.it
OBJECTIVE: The hypothesis that been set forward that use of Renin Angiotensin
Aldosterone System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a …
Aldosterone System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a …
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
A Di Castelnuovo, S Costanzo, A Antinori… - VASCULAR …, 2020 - boa.unimib.it
Objective: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
A Di Castelnuovo, S Costanzo, A Antinori… - VASCULAR …, 2020 - iris.unina.it
Objective: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID− 19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID− 19 severity. We set-up a multicenter …
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
A Di Castelnuovo, S Costanzo, A Antinori… - VASCULAR …, 2020 - iris.uniupo.it
Objective: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies.
A di Castelnuovo, S Costanzo, A Antinori, N Berselli… - 2020 - cabidigitallibrary.org
Objective: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
RAAS inhibitors are not associated with mortality in COVID-19 patients: Findings from an observational multicenter study in Italy and a meta-analysis of 19 studies
A Di Castelnuovo, S Costanzo, A Antinori… - VASCULAR …, 2020 - arpi.unipi.it
Objective: The hypothesis that been set forward that use of Renin Angiotensin Aldosterone
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …
System (RAAS) inhibitors is associated with COVID-19 severity. We set-up a multicenter …